Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 6, 1997, Pages 641-643

  Jacobs, B C ^a,b   Van Doorn, P A ^a   Groeneveld, J H M ^a   Tio Gillen, A P ^a   Van Der Meche F G A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anti GM2 antibodies; Cytomegalovirus; Guillain Barr ; Syndrome

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CHROMATOGRAPHY, THIN LAYER; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M2) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYRADICULONEUROPATHY;

EID: 0030996736     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.6.641     Document Type: Article

References (14)

1. Van der Meché FGA, van Doorn PA. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995;37(suppl):S14-31.
2. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
3. Jacobs BC, van Doorn PA, Schmitz PIM, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40: 181-7.
4. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178: 1771-5.
5. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-8.
6. Visser LH, van der Meché FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic and prognostic features. Neurology 1996;47:668-73.
7. Irie S, Saito T, Nakamura K, et al. Association between anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J Neuroimmunol 1996; 68:19-26.
8. Svennerholm L, Fredman P. Antibody detection in Guillain-Barré syndrome. Ann Neurol 1990;27(suppl): S36-40.
9. Van der Meché FGA, Schmitz PIM, the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326: 1123-9.
10. Kusunoki S, Chiba A, Hitoshi S, Takizawa H, Kanazawa I. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 1995; 18:409-13.
11. Ilyas AA, Mithen FA, Chen Z-W, Cook SD. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J Neuroimmunol 1992;36:69-76.
12. Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1995;130:112-6.
13. Aspinall GO, McDonald AG, Raju TS, Pang H, Moran AP, Penner JL. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur J Biochem 1993;213: 1017-27.
14. Hughes R, Atkinson P, Coates P, Hall S, Leibowitz S. Sural nerve biopsies in Guillain Barré syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992;15:568-75.